Hong Kong biotech start-up Prenetics plans $1.3 billion SPAC merger
Signage for Prenetics, a Hong Kong-based biotechnology company, at the company’s laboratory in Hong Kong, China, on Jan. 26, 2018. Anthony Kwan| Bloomberg | Getty Images Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company, in a deal that will value the new entity at $ 1.3… Read More »
